دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 30,000,000 تومان- قیمت ویژه : 6,250,000تومان
دسترسی یکماهه به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 31 ﺭﻭﺯ
قیمت : 3,000,000 تومان- قیمت ویژه : 1,250,000تومان
Distance and Likelihood of Cardiovascular Imaging Receipt Among Medicare Beneficiaries: Cardiovascular Imaging Deserts Among Medicare Beneficiaries
doi : 10.1016/j.jcmg.2025.10.018
Volume 19, Issue 4, April 2026, Pages 447-459
Beyond Proximity: The Need to Embed Health Equity Infrastructure in Access to Cardiovascular Imaging
doi : 10.1016/j.jcmg.2025.12.002
Volume 19, Issue 4, April 2026, Pages 460-462
Patient-Specific Registration of Segmental Jeopardy and Viability: Novel Method to Guide Revascularization in Ischemic Cardiomyopathy
doi : 10.1016/j.jcmg.2025.11.009
Volume 19, Issue 4, April 2026, Pages 463-474
Just When We Thought Viability Was in Jeopardy
doi : 10.1016/j.jcmg.2025.12.006
Volume 19, Issue 4, April 2026, Pages 475-477
Statin Effects on Pericoronary Adipose Tissue Density in People With HIV: Insights From the REPRIEVE Trial
doi : 10.1016/j.jcmg.2025.10.012
Volume 19, Issue 4, April 2026, Pages 478-489
Coronary Inflammatory Risk: A New Therapeutic Target in HIV?
doi : 10.1016/j.jcmg.2025.11.003
Volume 19, Issue 4, April 2026, Pages 490-493
Deep Learning and Fluid Dynamics On-Site CT-FFR Solution Compared to Off-Site FFRct and Invasive FFR
doi : 10.1016/j.jcmg.2025.11.011
Volume 19, Issue 4, April 2026, Pages 494-512
Navigating the Future of CT-FFR: Balancing Innovation, Access, and Practicality
doi : 10.1016/j.jcmg.2026.01.009
Volume 19, Issue 4, April 2026, Pages 513-515
Intracoronary Imaging and Transcriptomic Characteristics Before and After Maximum Lipid-Lowering Therapy: YELLOW-III Study of Evolocumab and Maximum Statin Therapy in Chronic Coronary Disease
doi : 10.1016/j.jcmg.2025.12.013
Volume 19, Issue 4, April 2026, Pages 516-534
Intertwining Intravascular Imaging and Transcriptomics to Identify Responsiveness to PCSK9 Inhibitor Therapy
doi : 10.1016/j.jcmg.2026.02.002
Volume 19, Issue 4, April 2026, Pages 535-537
Cardiovascular Imaging Considerations for Masters-Aged Athletes
doi : 10.1016/j.jcmg.2025.10.024
Volume 19, Issue 4, April 2026, Pages 538-550
Myocardial Scar in Hypertrophic Cardiomyopathy With Systolic Dysfunction: Functional and Prognostic Significance
doi : 10.1016/j.jcmg.2025.09.018
Volume 19, Issue 4, April 2026, Pages 551-554
Prediction of Left Ventricular Reverse Remodeling Using 18F-FAPI-74 PET/CT in Nonischemic Dilated Cardiomyopathy
doi : 10.1016/j.jcmg.2025.10.002
Volume 19, Issue 4, April 2026, Pages 555-557
Comparative Prognostic Value of LGE in LV Dilatation With Preserved LVEF and Dilated Cardiomyopathy
doi : 10.1016/j.jcmg.2025.10.008
Volume 19, Issue 4, April 2026, Pages 558-560
Treadmill Stress Echocardiography in Hypertrophic Cardiomyopathy: Ascertaining True Asymptomatic Status and Long-Term Prognosis
doi : 10.1016/j.jcmg.2025.11.001
Volume 19, Issue 4, April 2026, Pages 561-564
Digital Twin Model Predicts Prognosis in Pulmonary Arterial Hypertension
doi : 10.1016/j.jcmg.2025.11.006
Volume 19, Issue 4, April 2026, Pages 565-567
Access and Equity to CV Imaging Services: Complicated and Much More to Learn
doi : 10.1016/j.jcmg.2026.03.002
Volume 19, Issue 4, April 2026, Pages 568-569
